MORE►
Robin Autopilot Holdings
Logan Fahey, CEO of Robin Autopilot Holdings, and the building at 7850 Collin McKinney Parkway in McKinney, where the company will move its headquarters.
Robin Autopilot Is Robot-Mowing its Way to a New McKinney HQ
by David Seeley | Jun 1, 2021
The fast-growing robot tech company acquired N.C.-based Mowbot in April. Now, with a grant from the MEDC Innovation Fund, it's consolidating both by relocating to a new HQ in McKinney. The EDC's Danny Chavez says it's the largest fund relocation to date.
Related Articles
Calendar: Not-to-Miss Events for Innovators in Dallas-Fort Worth
Apply Now:
Opportunities for North Texas Innovators Unicorn Founders Take Center Stage at USICOC TechConnex 2025 On-Demand Pay Provider Tapcheck Raises $25M Series A Extension, $200M Debt Funding Pegasus Park Speaker Series To Offer ‘Insights From the Frontlines of Health Policy’ by Former FDA Leaders
Opportunities for North Texas Innovators Unicorn Founders Take Center Stage at USICOC TechConnex 2025 On-Demand Pay Provider Tapcheck Raises $25M Series A Extension, $200M Debt Funding Pegasus Park Speaker Series To Offer ‘Insights From the Frontlines of Health Policy’ by Former FDA Leaders
MORE►
Trending
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
More than two years since generative AI exploded onto the radar of business leaders, the technology continues to mature. In 2025, AI is capable of driving real results across the enterprise....
Veteran banking executive Eric Teal has been named chief investment officer of Dallas-based Comerica Inc. He will be responsible for providing enterprise-wide leadership of investment strategy, portfolio construction, and enhancement of the Comerica Investment Management brand, Comerica said....
Plano-based payment technology provider Fortis has appointed two industry veterans to its executive leadership team: Brad Bialas as chief commercial officer and Kimling Lam as chief marketing officer.
Fortis said the appointments position Fortis for its next phase of aggressive growth across the software and ERP ecosystem....
Marshelle Smith Warren, MD, has been appointed chief medical officer of Dallas-based Secretome Therapeutics, a clinical-stage biotechnology company that is pioneering therapies derived from neonatal cardiac progenitor cells (nCPCs).
The company said Warren is a highly experienced pharmaceutical executive with more than two decades of leadership in clinical development, translational medicine, and regulatory strategy across multiple therapeutic areas, including cell therapy, immunology, cardiovascular, and rare diseases....
Trending
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
More than two years since generative AI exploded onto the radar of business leaders, the technology continues to mature. In 2025, AI is capable of driving real results across the enterprise....
Veteran banking executive Eric Teal has been named chief investment officer of Dallas-based Comerica Inc. He will be responsible for providing enterprise-wide leadership of investment strategy, portfolio construction, and enhancement of the Comerica Investment Management brand, Comerica said....
Plano-based payment technology provider Fortis has appointed two industry veterans to its executive leadership team: Brad Bialas as chief commercial officer and Kimling Lam as chief marketing officer.
Fortis said the appointments position Fortis for its next phase of aggressive growth across the software and ERP ecosystem....
Marshelle Smith Warren, MD, has been appointed chief medical officer of Dallas-based Secretome Therapeutics, a clinical-stage biotechnology company that is pioneering therapies derived from neonatal cardiac progenitor cells (nCPCs).
The company said Warren is a highly experienced pharmaceutical executive with more than two decades of leadership in clinical development, translational medicine, and regulatory strategy across multiple therapeutic areas, including cell therapy, immunology, cardiovascular, and rare diseases....
